Lisa Diane Hisaw, MD
Dermatology · Richmond
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hisaw’s office at (510) 307-1500 to ask if they take your plan before you enroll.
California Medical Board record
Licence A141079 · Current
Licensed to practise in California · since 2016 · expires 2028-03-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Skin biopsy | 1-10 | None |
Medicaid work
$1,435 in 2024
Medicaid paid $1,435 for 25 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 25 | $1,435 |
| 2024 | 25 | 1 | 13 | $1,435 |
| 2023 | 14 | 1 | 14 | $0 |
| 2020 | 53 | 2 | 14 | $39 |
| 2019 | 57 | 2 | 14 | $0 |
| 2018 | 13 | 1 | 13 | $0 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 14 | $0 |
2020
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $39 |
| Short return visit (20+ min) | 41 | $0 |
2019
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $0 |
| Short return visit (20+ min) | 45 | $0 |
2018
| Short return visit (20+ min) | 13 | $0 |
Drugs they prescribed that Part D paid
$496,130
Pharmacies billed $496,130 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 686) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
560 generic and 126 brand-name prescriptions · $496,130 in drug cost · 29 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cosentyx Sensoready (2 Pens) | 14 | $127,603 | $9,115 |
| Otezla | 29 | $119,414 | $4,118 |
| Amjevita(Cf) | 16 | $14,627 | $914 |
| Betamethasone Diprop Augmented | 55 | $4,518 | $82 |
| Tacrolimus | 31 | $4,290 | $138 |
See all 21 drugs
| Cosentyx Sensoready (2 Pens) | 14 | $127,603 | $9,115 |
| Otezla | 29 | $119,414 | $4,118 |
| Amjevita(Cf) | 16 | $14,627 | $914 |
| Betamethasone Diprop Augmented | 55 | $4,518 | $82 |
| Tacrolimus | 31 | $4,290 | $138 |
| Clobetasol Propionate | 92 | $3,120 | $34 |
| Alclometasone Dipropionate | 28 | $1,987 | $71 |
| Calcipotriene | 14 | $1,449 | $103 |
| Fluocinonide | 37 | $998 | $27 |
| Mycophenolate Mofetil | 16 | $855 | $53 |
| Triamcinolone Acetonide | 31 | $727 | $23 |
| Doxycycline Monohydrate | 19 | $682 | $36 |
| Retin-A | 26 | $571 | $22 |
| Desonide | 17 | $529 | $31 |
| Ketoconazole | 30 | $516 | $17 |
| Fluorouracil | 12 | $487 | $41 |
| Hydrocortisone | 12 | $405 | $34 |
| Clindamycin Phosphate | 12 | $362 | $30 |
| Mupirocin | 29 | $351 | $12 |
| Metronidazole | 12 | $300 | $25 |
| Prednisone | 11 | $106 | $10 |
Year by year
| 2024 | 686 | 216 | 0% (0) | 18% | $496,130 |
| 2023 | 947 | 315 | 0% (0) | 16% | $482,140 |
| 2022 | 523 | 210 | 0% (0) | 11% | $143,618 |
| 2021 | 669 | 243 | 0% (0) | 13% | $204,488 |
| 2020 | 714 | 306 | 0% (0) | 12% | $130,049 |
| 2019 | 842 | 340 | 0% (0) | 15% | $102,820 |
| 2018 | 178 | 98 | 0% (0) | 7% | $14,132 |
| 2017 | 18 | None | 0% (0) | 0% | $1,839 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Cosentyx Sensoready (2 Pens) | 36 | $143,662 | $3,991 |
| Otezla | 22 | $86,829 | $3,947 |
| Dupixent | 15 | $52,161 | $3,477 |
| Betamethasone Diprop Augmented | 75 | $5,346 | $71 |
| Clobetasol Propionate | 130 | $4,652 | $36 |
| Tacrolimus | 38 | $4,632 | $122 |
| Vectical | 22 | $4,399 | $200 |
| Alclometasone Dipropionate | 53 | $2,948 | $56 |
| Fluocinonide | 49 | $2,455 | $50 |
| Calcipotriene | 21 | $2,257 | $107 |
| Triamcinolone Acetonide | 42 | $1,303 | $31 |
| Fluorouracil | 31 | $1,281 | $41 |
| Mupirocin | 66 | $905 | $14 |
| Clindamycin Phosphate | 25 | $867 | $35 |
| Dexamethasone | 11 | $781 | $71 |
| Fluocinolone Acetonide | 20 | $657 | $33 |
| Fluocinolone Acetonide | 21 | $656 | $31 |
| Ketoconazole | 31 | $624 | $20 |
| Retin-A | 19 | $525 | $28 |
| Doxycycline Monohydrate | 17 | $488 | $29 |
| Metronidazole | 21 | $430 | $20 |
| Hydrocortisone | 20 | $359 | $18 |
| Prednisone | 11 | $168 | $15 |
| Minoxidil | 14 | $129 | $9 |
2022: 19 drugs
| Humira | 11 | $49,345 | $4,486 |
| Tacrolimus | 20 | $3,164 | $158 |
| Clobetasol Propionate | 70 | $2,792 | $40 |
| Vectical | 12 | $2,643 | $220 |
| Betamethasone Diprop Augmented | 32 | $2,097 | $66 |
| Alclometasone Dipropionate | 34 | $1,901 | $56 |
| Fluocinonide | 43 | $1,765 | $41 |
| Fluorouracil | 16 | $901 | $56 |
| Retin-A | 13 | $718 | $55 |
| Fluocinolone Acetonide | 11 | $632 | $57 |
| Clindamycin Phosphate | 17 | $621 | $37 |
| Metronidazole | 19 | $606 | $32 |
| Mupirocin | 38 | $498 | $13 |
| Triamcinolone Acetonide | 26 | $498 | $19 |
| Ketoconazole | 21 | $376 | $18 |
| Doxycycline Monohydrate | 11 | $241 | $22 |
| Hydrocortisone | 16 | $225 | $14 |
| Prednisone | 14 | $143 | $10 |
| Minoxidil | 13 | $138 | $11 |
2021: 18 drugs
| Otezla | 18 | $61,858 | $3,437 |
| Humira | 11 | $46,204 | $4,200 |
| Betamethasone Diprop Augmented | 82 | $9,618 | $117 |
| Clobetasol Propionate | 77 | $5,182 | $67 |
| Fluocinonide | 57 | $3,377 | $59 |
| Alclometasone Dipropionate | 54 | $3,366 | $62 |
| Tacrolimus | 23 | $3,017 | $131 |
| Vectical | 18 | $2,950 | $164 |
| Metronidazole | 16 | $910 | $57 |
| Fluocinolone Acetonide | 27 | $900 | $33 |
| Fluorouracil | 14 | $818 | $58 |
| Mupirocin | 51 | $778 | $15 |
| Clindamycin Phosphate | 18 | $651 | $36 |
| Triamcinolone Acetonide | 37 | $646 | $17 |
| Doxycycline Monohydrate | 19 | $565 | $30 |
| Ketoconazole | 17 | $349 | $21 |
| Hydrocortisone | 17 | $256 | $15 |
| Prednisone | 14 | $185 | $13 |
2020: 15 drugs
| Betamethasone Diprop Augmented | 92 | $9,585 | $104 |
| Clobetasol Propionate | 72 | $5,346 | $74 |
| Fluocinonide | 71 | $4,306 | $61 |
| Alclometasone Dipropionate | 33 | $3,040 | $92 |
| Tacrolimus | 16 | $2,113 | $132 |
| Vectical | 15 | $2,093 | $140 |
| Fluocinolone Acetonide | 39 | $1,498 | $38 |
| Triamcinolone Acetonide | 62 | $1,389 | $22 |
| Clindamycin Phosphate | 33 | $1,162 | $35 |
| Metronidazole | 17 | $993 | $58 |
| Fluorouracil | 14 | $889 | $63 |
| Mupirocin | 58 | $823 | $14 |
| Ketoconazole | 33 | $685 | $21 |
| Hydrocortisone | 27 | $546 | $20 |
| Doxycycline Monohydrate | 17 | $504 | $30 |
2019: 17 drugs
| Betamethasone Diprop Augmented | 103 | $7,997 | $78 |
| Clobetasol Propionate | 55 | $6,331 | $115 |
| Fluocinonide | 87 | $5,970 | $69 |
| Tacrolimus | 25 | $3,749 | $150 |
| Fluocinolone Acetonide | 69 | $3,403 | $49 |
| Triamcinolone Acetonide | 74 | $2,345 | $32 |
| Alclometasone Dipropionate | 31 | $2,257 | $73 |
| Clindamycin Phosphate | 46 | $1,792 | $39 |
| Fluorouracil | 24 | $1,669 | $70 |
| Metronidazole | 23 | $1,387 | $60 |
| Vectical | 11 | $1,332 | $121 |
| Mupirocin | 54 | $733 | $14 |
| Hydrocortisone | 53 | $653 | $12 |
| Doxycycline Monohydrate | 15 | $476 | $32 |
| Ketoconazole | 21 | $457 | $22 |
| Imiquimod | 11 | $309 | $28 |
| Ciclopirox | 11 | $198 | $18 |
2018: 8 drugs
| Fluocinonide | 14 | $1,411 | $101 |
| Fluocinolone Acetonide | 17 | $1,111 | $65 |
| Triamcinolone Acetonide | 19 | $634 | $33 |
| Betamethasone Diprop Augmented | 12 | $473 | $39 |
| Clindamycin Phosphate | 12 | $418 | $35 |
| Ketoconazole | 16 | $401 | $25 |
| Mupirocin | 18 | $252 | $14 |
| Hydrocortisone | 11 | $119 | $11 |
Money from drug and device companies
$59 in 2025
| 2025 | 1 | 1 | None | $59 |
| 2024 | 1 | 2 | None | $113 |
| 2022 | 1 | 1 | None | $72 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Sotyktu | $59 | 1 payment
|
See the published payment
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-24 | Sotyktu | $59 |
See earlier years (2024, 2022)
2024: $113
| E.R. Squibb & Sons L.L.C. | Sotyktu | $113 | 2 payments
|
2022: $72
| Pfizer | Cibinqo | $72 | 1 payment
|
Professional record
- NPI
- 1619395597
- Licence
- CA A141079California A141079: Current · expires 2028-03-31
- Trained
- University of California, Irvine, California College of Medicine, 2014
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Student in a training program (390200000X)
- Mailing address
- 710 Lawrence Expy, Gme Dept. 384, Santa Clara, CA, 95051
- NPI first listed
- 2014-03-28
- NPI last updated
- 2021-12-17
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.